Cargando…
The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease
In Parkinson’s disease, there is a progressive reduction in striatal dopaminergic function, and loss of neuromelanin-containing dopaminergic neurons and increased iron deposition in the substantia nigra. We tested the hypothesis of a relationship between impairment of the dopaminergic system and cha...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634084/ https://www.ncbi.nlm.nih.gov/pubmed/33978742 http://dx.doi.org/10.1093/brain/awab191 |
_version_ | 1784608064544964608 |
---|---|
author | Biondetti, Emma Santin, Mathieu D Valabrègue, Romain Mangone, Graziella Gaurav, Rahul Pyatigorskaya, Nadya Hutchison, Matthew Yahia-Cherif, Lydia Villain, Nicolas Habert, Marie-Odile Arnulf, Isabelle Leu-Semenescu, Smaranda Dodet, Pauline Vila, Miquel Corvol, Jean-Christophe Vidailhet, Marie Lehéricy, Stéphane |
author_facet | Biondetti, Emma Santin, Mathieu D Valabrègue, Romain Mangone, Graziella Gaurav, Rahul Pyatigorskaya, Nadya Hutchison, Matthew Yahia-Cherif, Lydia Villain, Nicolas Habert, Marie-Odile Arnulf, Isabelle Leu-Semenescu, Smaranda Dodet, Pauline Vila, Miquel Corvol, Jean-Christophe Vidailhet, Marie Lehéricy, Stéphane |
author_sort | Biondetti, Emma |
collection | PubMed |
description | In Parkinson’s disease, there is a progressive reduction in striatal dopaminergic function, and loss of neuromelanin-containing dopaminergic neurons and increased iron deposition in the substantia nigra. We tested the hypothesis of a relationship between impairment of the dopaminergic system and changes in the iron metabolism. Based on imaging data of patients with prodromal and early clinical Parkinson’s disease, we assessed the spatiotemporal ordering of such changes and relationships in the sensorimotor, associative and limbic territories of the nigrostriatal system. Patients with Parkinson’s disease (disease duration < 4 years) or idiopathic REM sleep behaviour disorder (a prodromal form of Parkinson’s disease) and healthy controls underwent longitudinal examination (baseline and 2-year follow-up). Neuromelanin and iron sensitive MRI and dopamine transporter single-photon emission tomography were performed to assess nigrostriatal levels of neuromelanin, iron, and dopamine. For all three functional territories of the nigrostriatal system, in the clinically most and least affected hemispheres separately, the following was performed: cross-sectional and longitudinal intergroup difference analysis of striatal dopamine and iron, and nigral neuromelanin and iron; in Parkinson’s disease patients, exponential fitting analysis to assess the duration of the prodromal phase and the temporal ordering of changes in dopamine, neuromelanin or iron relative to controls; and voxel-wise correlation analysis to investigate concomitant spatial changes in dopamine-iron, dopamine-neuromelanin and neuromelanin-iron in the substantia nigra pars compacta. The temporal ordering of dopaminergic changes followed the known spatial pattern of progression involving first the sensorimotor, then the associative and limbic striatal and nigral regions. Striatal dopaminergic denervation occurred first followed by abnormal iron metabolism and finally neuromelanin changes in the substantia nigra pars compacta, which followed the same spatial and temporal gradient observed in the striatum but shifted in time. In conclusion, dopaminergic striatal dysfunction and cell loss in the substantia nigra pars compacta are interrelated with increased nigral iron content. |
format | Online Article Text |
id | pubmed-8634084 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-86340842021-12-01 The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease Biondetti, Emma Santin, Mathieu D Valabrègue, Romain Mangone, Graziella Gaurav, Rahul Pyatigorskaya, Nadya Hutchison, Matthew Yahia-Cherif, Lydia Villain, Nicolas Habert, Marie-Odile Arnulf, Isabelle Leu-Semenescu, Smaranda Dodet, Pauline Vila, Miquel Corvol, Jean-Christophe Vidailhet, Marie Lehéricy, Stéphane Brain Original Articles In Parkinson’s disease, there is a progressive reduction in striatal dopaminergic function, and loss of neuromelanin-containing dopaminergic neurons and increased iron deposition in the substantia nigra. We tested the hypothesis of a relationship between impairment of the dopaminergic system and changes in the iron metabolism. Based on imaging data of patients with prodromal and early clinical Parkinson’s disease, we assessed the spatiotemporal ordering of such changes and relationships in the sensorimotor, associative and limbic territories of the nigrostriatal system. Patients with Parkinson’s disease (disease duration < 4 years) or idiopathic REM sleep behaviour disorder (a prodromal form of Parkinson’s disease) and healthy controls underwent longitudinal examination (baseline and 2-year follow-up). Neuromelanin and iron sensitive MRI and dopamine transporter single-photon emission tomography were performed to assess nigrostriatal levels of neuromelanin, iron, and dopamine. For all three functional territories of the nigrostriatal system, in the clinically most and least affected hemispheres separately, the following was performed: cross-sectional and longitudinal intergroup difference analysis of striatal dopamine and iron, and nigral neuromelanin and iron; in Parkinson’s disease patients, exponential fitting analysis to assess the duration of the prodromal phase and the temporal ordering of changes in dopamine, neuromelanin or iron relative to controls; and voxel-wise correlation analysis to investigate concomitant spatial changes in dopamine-iron, dopamine-neuromelanin and neuromelanin-iron in the substantia nigra pars compacta. The temporal ordering of dopaminergic changes followed the known spatial pattern of progression involving first the sensorimotor, then the associative and limbic striatal and nigral regions. Striatal dopaminergic denervation occurred first followed by abnormal iron metabolism and finally neuromelanin changes in the substantia nigra pars compacta, which followed the same spatial and temporal gradient observed in the striatum but shifted in time. In conclusion, dopaminergic striatal dysfunction and cell loss in the substantia nigra pars compacta are interrelated with increased nigral iron content. Oxford University Press 2021-05-12 /pmc/articles/PMC8634084/ /pubmed/33978742 http://dx.doi.org/10.1093/brain/awab191 Text en © The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Articles Biondetti, Emma Santin, Mathieu D Valabrègue, Romain Mangone, Graziella Gaurav, Rahul Pyatigorskaya, Nadya Hutchison, Matthew Yahia-Cherif, Lydia Villain, Nicolas Habert, Marie-Odile Arnulf, Isabelle Leu-Semenescu, Smaranda Dodet, Pauline Vila, Miquel Corvol, Jean-Christophe Vidailhet, Marie Lehéricy, Stéphane The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease |
title | The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease |
title_full | The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease |
title_fullStr | The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease |
title_full_unstemmed | The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease |
title_short | The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease |
title_sort | spatiotemporal changes in dopamine, neuromelanin and iron characterizing parkinson’s disease |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634084/ https://www.ncbi.nlm.nih.gov/pubmed/33978742 http://dx.doi.org/10.1093/brain/awab191 |
work_keys_str_mv | AT biondettiemma thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT santinmathieud thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT valabregueromain thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT mangonegraziella thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT gauravrahul thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT pyatigorskayanadya thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT hutchisonmatthew thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT yahiacheriflydia thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT villainnicolas thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT habertmarieodile thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT arnulfisabelle thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT leusemenescusmaranda thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT dodetpauline thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT vilamiquel thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT corvoljeanchristophe thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT vidailhetmarie thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT lehericystephane thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT biondettiemma spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT santinmathieud spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT valabregueromain spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT mangonegraziella spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT gauravrahul spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT pyatigorskayanadya spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT hutchisonmatthew spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT yahiacheriflydia spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT villainnicolas spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT habertmarieodile spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT arnulfisabelle spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT leusemenescusmaranda spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT dodetpauline spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT vilamiquel spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT corvoljeanchristophe spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT vidailhetmarie spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease AT lehericystephane spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease |